Free tool
FAERS Monitor: Micardis Hct
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021162 or its brand name (Micardis Hct, Hydrochlorothiazide, Telmisartan). Reports on generic versions are filed under their own applications.
Reports
2,358
Serious
1,474
63% of reports
Hospitalization
760
Death reported
145
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dizziness152
- drug ineffective120
- nausea118
- fatigue112
- headache111
- blood pressure increased105
- diarrhoea96
- dyspnoea93
- hypotension84
- hypertension83
- fall81
- vomiting79
- asthenia75
- arthralgia72
- pain71
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 48 |
| 2005 | 58 |
| 2006 | 80 |
| 2007 | 132 |
| 2008 | 189 |
| 2009 | 186 |
| 2010 | 243 |
| 2011 | 245 |
| 2012 | 218 |
| 2013 | 104 |
| 2014 | 100 |
| 2015 | 97 |
| 2016 | 101 |
| 2017 | 80 |
| 2018 | 88 |
| 2019 | 76 |
| 2020 | 66 |
| 2021 | 51 |
| 2022 | 30 |
| 2023 | 39 |
| 2024 | 34 |
| 2025 | 63 |
| 2026 | 30 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,801 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood pressure increasedSignal | 105 | 6.1 | 5.1 | 449 |
| hypotensionSignal | 84 | 3.7 | 3.0 | 167 |
| hypertensionSignal | 83 | 3.5 | 2.8 | 147 |
| dizzinessSignal | 152 | 2.7 | 2.3 | 167 |
| fallSignal | 81 | 2.2 | 1.8 | 51 |
| asthenia | 75 | 1.8 | 1.4 | 25 |
| headache | 111 | 1.6 | 1.3 | 24 |
| arthralgia | 72 | 1.5 | 1.2 | 14 |
| vomiting | 79 | 1.5 | 1.2 | 13 |
| dyspnoea | 93 | 1.5 | 1.2 | 14 |
| nausea | 118 | 1.3 | 1.1 | 10 |
| diarrhoea | 96 | 1.3 | 1.1 | 8 |
| fatigue | 112 | 1.3 | 1.1 | 7 |
| pain | 71 | 1.0 | 0.8 | 0 |
| drug ineffective | 120 | 0.8 | 0.7 | 5 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.